KALAMAZOO, Michigan, USA, Feb. 15, 2018 /PRNewswire/ — The Food and Drug Administration (FDA) has expanded the indication for Stryker’s Trevo Retriever as a front-line treatment for patients experiencing acute ischemic stroke up to 24 hours from symptom onset – increasing the treatment…
